Hanqiao Shao
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Comparing and Selecting Network Meta-Analysis Models for Cost-Effectiveness Analysis of Anticancer Drugs.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: July 24, 2026
Comparison and Selection of Network Meta-Analysis Models for Fitting and Extrapolating Cancer Survival Data.
Journal: Journal of evidence-based medicine
Published: June 18, 2026
Estimating Overall Survival Treatment Effects in Oncology Trials: Hazard Ratio Instability and RMST as a Robust, Internally Predictive Complement.
Journal: Journal of clinical epidemiology
Published: March 13, 2026
Economic evidence of alternative formulations and routes of administration for identical active pharmaceutical ingredient: a systematic review.
Journal: Health economics review
Published: December 16, 2025
Cost-effectiveness of avacopan for ANCA-associated vasculitis in China.
Journal: Clinical and experimental rheumatology
Published: November 13, 2025
Adverse Event Costs and Cost-Effectiveness Analyses of Anticancer Drugs: A Systematic Review.
Journal: JAMA network open
Published: May 27, 2025
Optimizing treatment and sequencing strategies for maximal survival and net health benefits in ALK-positive NSCLC: a systematic review and reconstructed individual patient data meta-analysis.
Journal: BMC cancer
Published: September 16, 2024
Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective.
Journal: Cost effectiveness and resource allocation : C/E
Published: April 16, 2024
Comparing the cost-benefit of breast cancer screening programs in rural and urban areas across four economic zones in China: a Markov modeling analysis.
Journal: BMC public health
Published: November 15, 2023
Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?
Journal: Cost effectiveness and resource allocation : C/E
Published: November 15, 2023
QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: November 10, 2023
Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis.
Journal: BMC cancer
Published: November 01, 2023
Last Updated: 09/26/2026